MRM Medirom Healthcare Technologies Inc. Annual reports only
Services-Personal Services · Nasdaq · SEC CIK 1819704 · Reporting currency JPY · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY21.5%
TTM net income YoY28.9%
TTM EPS YoY27.7%
Revenue 3-yr CAGR15.3%
Net income 3-yr CAGR—
Margins
Gross margin27.1%
Operating margin-0.2%
Net margin1.8%
FCF margin-16.9%
EBITDA margin3.3%
Returns
ROE26.0%
ROA2.0%
ROIC (approx.)-1.1%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets85.3%
Debt / equity1.48x
Current ratio0.65x
Interest coverage-0.36x
Cash quality & payout
Operating cash flow / net income-8.95x
Accruals ratio19.8%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: JPY | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 6.23B | 8.30B |
| Cost of revenue | — | 6.05B |
| Gross profit | — | 2.25B |
| SG&A expense | 2.57B | 2.24B |
| Operating income | -3.39B | -18.10M |
| Interest expense | 66.19M | 49.74M |
| Pretax income | -3.34B | 47.71M |
| Income tax | 304.12M | -90.48M |
| Net income | -3.63B | 148.76M |
| EBITDA | -2.86B | 271.94M |
| EPS (basic) | -459.92 | 29.13 |
| EPS (diluted) | -459.92 | 28.52 |
| Weighted avg. shares (diluted) | 7.90M | 5.85M |
| Balance sheet | ||
| Cash & equivalents | 91.98M | 329.40M |
| Short-term investments | 6.16M | 6.16M |
| Receivables | 671.66M | 1.36B |
| Inventory | 156.62M | 151.64M |
| Current assets | 1.49B | 2.71B |
| PP&E, net | 154.62M | 435.66M |
| Goodwill | 0 | 389.13M |
| Intangibles | 862.65M | 1.14B |
| Total assets | 4.68B | 8.09B |
| Current liabilities | 4.73B | 4.18B |
| Short-term debt | 161.32M | 620.81M |
| Long-term debt | 799.96M | 764.20M |
| Total debt | 961.28M | 1.39B |
| Total liabilities | 7.11B | 6.90B |
| Shareholders' equity | -2.67B | 933.27M |
| Net debt | 869.30M | 1.06B |
| Shares outstanding | 7.90M | 2,024 |
| Cash flow statement | ||
| Operating cash flow | -1.16B | -1.33B |
| Capital expenditure | 10.30M | 71.41M |
| Free cash flow | -1.17B | -1.40B |
| Investing cash flow | -22.46M | 361.39M |
| Financing cash flow | 940.04M | 1.19B |
| Depreciation & amortization | 532.66M | 290.04M |
| Stock-based compensation | 0 | — |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, JPY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.